Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/1b pevonedistat ± azacitidine in East Asian AML/MDS
jRCT2080223194Phase 1Completed
- Sponsor
- Takeda
- Start
- May 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of pevonedistat in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) (4 arms), sponsored by Takeda. Started May 2016; status: completed.
02
Drugs
pevonedistat
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on jRCT2080223194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223194.